Literature DB >> 15841102

Disruption of rat forebrain development by glucocorticoids: critical perinatal periods for effects on neural cell acquisition and on cell signaling cascades mediating noradrenergic and cholinergic neurotransmitter/neurotrophic responses.

Marisa L Kreider1, Justin E Aldridge, Mandy M Cousins, Colleen A Oliver, Frederic J Seidler, Theodore A Slotkin.   

Abstract

Glucocorticoids are the consensus treatment for the prevention of respiratory distress in preterm infants, but there is evidence for increased incidence of neurodevelopmental disorders as a result of their administration. We administered dexamethasone (Dex) to developing rats at doses below or within the range of those used clinically, evaluating the effects on forebrain development with exposure in three different stages: gestational days 17-19, postnatal days 1-3, or postnatal days 7-9. At 24 h after the last dose, we evaluated biomarkers of neural cell acquisition and growth, synaptic development, neurotransmitter receptor expression, and synaptic signaling mediated by adenylyl cyclase (AC). Dex impaired the acquisition of neural cells, with a peak effect when given in the immediate postnatal period. In association with this defect, Dex also elicited biphasic effects on cholinergic presynaptic development, promoting synaptic maturation at a dose (0.05 mg/kg) well below those used therapeutically, whereas the effect was diminished or lost when doses were increased to 0.2 or 0.8 mg/kg. Dex given postnatally also disrupted the expression of adrenergic receptors known to participate in neurotrophic modeling of the developing brain and evoked massive induction of AC activity. As a consequence, disparate receptor inputs all produced cyclic AMP overproduction, a likely contributor to disrupted patterns of cell replication, differentiation, and apoptosis. Superimposed on the heterologous AC induction, Dex impaired specific receptor-mediated cholinergic and adrenergic signals. These results indicate that, during a critical developmental period, Dex administration leads to widespread interference with forebrain development, likely contributing to eventual, adverse neurobehavioral outcomes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15841102     DOI: 10.1038/sj.npp.1300743

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  11 in total

1.  Prenatal dexamethasone augments the neurobehavioral teratology of chlorpyrifos: significance for maternal stress and preterm labor.

Authors:  Edward D Levin; Marty Cauley; Joshua E Johnson; Ellen M Cooper; Heather M Stapleton; P Lee Ferguson; Frederic J Seidler; Theodore A Slotkin
Journal:  Neurotoxicol Teratol       Date:  2013-10-28       Impact factor: 3.763

2.  Prenatal dexamethasone augments the sex-selective developmental neurotoxicity of chlorpyrifos: implications for vulnerability after pharmacotherapy for preterm labor.

Authors:  Theodore A Slotkin; Jennifer Card; Alice Infante; Frederic J Seidler
Journal:  Neurotoxicol Teratol       Date:  2013-02-14       Impact factor: 3.763

3.  Induction of tyrosine hydroxylase gene expression by glucocorticoids in the perinatal rat brain is age-dependent.

Authors:  Tatyana S Kalinina; Galina T Shishkina; Nikolay N Dygalo
Journal:  Neurochem Res       Date:  2012-01-03       Impact factor: 3.996

4.  Disparate developmental neurotoxicants converge on the cyclic AMP signaling cascade, revealed by transcriptional profiles in vitro and in vivo.

Authors:  Abayomi A Adigun; Frederic J Seidler; Theodore A Slotkin
Journal:  Brain Res       Date:  2009-12-21       Impact factor: 3.252

5.  Mimicking maternal smoking and pharmacotherapy of preterm labor: fetal nicotine exposure enhances the effect of late gestational dexamethasone treatment on noradrenergic circuits.

Authors:  Theodore A Slotkin; Frederic J Seidler
Journal:  Brain Res Bull       Date:  2011-08-19       Impact factor: 4.077

6.  Prenatal nicotine alters the developmental neurotoxicity of postnatal chlorpyrifos directed toward cholinergic systems: better, worse, or just "different?".

Authors:  Theodore A Slotkin; Frederic J Seidler
Journal:  Brain Res Bull       Date:  2014-12-12       Impact factor: 4.077

7.  Prenatal dexamethasone, as used in preterm labor, worsens the impact of postnatal chlorpyrifos exposure on serotonergic pathways.

Authors:  Theodore A Slotkin; Jennifer Card; Frederic J Seidler
Journal:  Brain Res Bull       Date:  2013-11-23       Impact factor: 4.077

8.  Neonatal dexamethasone treatment leads to alterations in cell signaling cascades controlling hepatic and cardiac function in adulthood.

Authors:  Abayomi A Adigun; Nicola Wrench; Frederic J Seidler; Theodore A Slotkin
Journal:  Neurotoxicol Teratol       Date:  2009-10-20       Impact factor: 3.763

9.  Prenatal drug exposures sensitize noradrenergic circuits to subsequent disruption by chlorpyrifos.

Authors:  Theodore A Slotkin; Samantha Skavicus; Frederic J Seidler
Journal:  Toxicology       Date:  2015-09-28       Impact factor: 4.221

10.  Could oxidative stress from psychosocial stress affect neurodevelopment in autism?

Authors:  Woody R McGinnis
Journal:  J Autism Dev Disord       Date:  2007-04-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.